Table 4 Univariate analysis of ERCP-related adverse events in patients with and without a history of EST, calculated by ERCP sessions
Adverse events | History of EST | No history of EST (naïve papilla) | P-value | |
|---|---|---|---|---|
All adverse events | 10.8% (20/185) | 19.0% (52/273) | 0.017 | |
Pancreatitis | Mild Moderate Severe | 0.5% (1/185) 0.5% (1/185) – | 9.5% (26/273) 1.8% (5/273) 0.7% (2/273) | < 0.001 |
Cholangitis | 9.7% (18/185) | 6.2% (17/273) | 0.166 | |
Cholecystitis | – | 0.4% (1/273) | 0.410 | |